Form 4: Bioventus Inc. CEO Sells Shares to Cover Taxes After Vesting

Bioventus Inc.'s CEO, Robert E. Claypoole, sold 28,786 shares of Class A Common Stock to cover taxes following the vesting of restricted stock units.

Summary

• Robert E. Claypoole, the President and CEO of Bioventus Inc., sold 28,786 shares of Class A Common Stock on January 13, 2025.
• The sale was executed to cover taxes associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $9.1, with individual transactions ranging from $8.935 to $9.22.
• Following the transaction, Claypoole directly owns 64,964 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for an executive to cover tax obligations, which is neither positive nor negative for the company's overall performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover taxes are a common practice across publicly traded companies.
• The use of a 10b5-1 trading plan is a standard method for insiders to avoid accusations of trading on non-public information.
• The price range of $8.935 to $9.22 is within a normal range for a stock sale of this type.

Stakeholder Impact

• The stock sale by the CEO may have a minor impact on the stock price, but it is unlikely to be significant given the pre-arranged nature of the transaction.

Key Dates

Keywords

Bioventus Inc., Robert E. Claypoole, stock sale, insider trading, Form 4, restricted stock units, tax obligations